Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Trading indicators?….Onc

<< Previous

Bullboard Posts

Next >>

Comment by askretkaon Sep 09, 2022 2:52pm

256 Views

Post# 34952896

RE:Trading indicators?….Onc

Ya stock is actually hard to buy. If you want a larger block right now. Interesting. I bought 1000 shares as a test and it took 5 trades to get it went through as 100, 200, 400, 200 and 100. The other day. Usually its pretty easy to get 1000 shares as one block?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec